Program 1 included hallmark CRS cytokines and CRS mediators indicative of T-cell (IL-2) and myeloid cell activation (IL-6 and CXCL8 (IL-8, CCL2 and sIL-1R); Fig. 3d and Extended Data Fig. 2). This evidence concerns the gene CCL2 and congenital rubella syndrome.